Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 479

1.

Biological responses following one-stage full-mouth scaling and root planing with and without azithromycin: Multicenter randomized trial.

Yashima A, Morozumi T, Yoshie H, Hokari T, Izumi Y, Akizuki T, Mizutani K, Takamatsu H, Minabe M, Miyauchi S, Yoshino T, Tanaka M, Tanaka Y, Gomi K.

J Periodontal Res. 2019 Jul 10. doi: 10.1111/jre.12680. [Epub ahead of print]

PMID:
31292965
2.

Metabolomics analysis of blood identifies potential biomarkers and possible treatment targets for nocturia.

Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Takeda M.

Ther Adv Urol. 2019 May 17;11:1756287219850087. doi: 10.1177/1756287219850087. eCollection 2019 Jan-Dec.

3.

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jul;110(1):125-126. doi: 10.1007/s12185-019-02663-5.

PMID:
31119612
4.

Response to: 'Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?' by Liu et al.

Kato Y, Park J, Takamatsu H, Kumanogoh A.

Ann Rheum Dis. 2019 May 16. pii: annrheumdis-2019-215540. doi: 10.1136/annrheumdis-2019-215540. [Epub ahead of print] No abstract available.

PMID:
31097418
5.

Low-Voltage Irreversible Electroporation Using a Comb-Shaped Contact Electrode.

Kurata K, Yoshimatsu S, Takamatsu H.

IEEE Trans Biomed Eng. 2019 May 3. doi: 10.1109/TBME.2019.2914689. [Epub ahead of print]

PMID:
31059422
6.

Upregulation of mobility in pancreatic cancer cells by secreted S100A11 through activation of surrounding fibroblasts.

Mitsui Y, Tomonobu N, Watanabe M, Kinoshita R, Sumardika W, Youyi C, Murata H, Yamamoto KI, Sadahira T, Rodrigo AGH, Takamatsu H, Araki K, Yamauchi A, Yamamura M, Fujiwara H, Inoue Y, Futami J, Saito K, Iioka H, Kondo E, Nishibori M, Toyooka S, Yamamoto Y, Nasu Y, Sakaguchi M.

Oncol Res. 2019 Apr 17. doi: 10.3727/096504019X15555408784978. [Epub ahead of print]

PMID:
31046874
7.

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).

Sunami K, Matsumoto M, Fuchida SI, Omoto E, Takamatsu H, Adachi Y, Choi I, Fujishima N, Kiguchi T, Miyamoto T, Maeda A, Suzumiya J, Yamamura R, Nagafuji K, Nakazato T, Kuroda Y, Yujiri T, Takamatsu Y, Harada M, Akashi K.

Int J Clin Oncol. 2019 Aug;24(8):966-975. doi: 10.1007/s10147-019-01436-8. Epub 2019 Apr 1.

PMID:
30937622
8.

Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):505. doi: 10.1007/s12185-019-02621-1.

PMID:
30903563
9.

Effect of ASP2205 fumarate, a novel 5-HT2C receptor agonist, on urethral closure function in rats.

Ishigami T, Ueshima K, Ukai M, Asai N, Takamatsu H, Yokono M, Takeda M, Masuda N.

J Pharmacol Sci. 2019 Apr;139(4):333-339. doi: 10.1016/j.jphs.2019.02.004. Epub 2019 Feb 27.

10.

Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.

Takamatsu H, Yamamoto KI, Tomonobu N, Murata H, Inoue Y, Yamauchi A, Sumardika IW, Chen Y, Kinoshita R, Yamamura M, Fujiwara H, Mitsui Y, Araki K, Futami J, Saito K, Iioka H, Ruma IMW, Putranto EW, Nishibori M, Kondo E, Yamamoto Y, Toyooka S, Sakaguchi M.

Oncol Res. 2019 Jun 21;27(6):713-727. doi: 10.3727/096504018X15433161908259. Epub 2019 Mar 8.

PMID:
30850029
11.

Distinguishing analgesic drugs from non-analgesic drugs based on brain activation in macaques with oxaliplatin-induced neuropathic pain.

Shidahara Y, Natsume T, Awaga Y, Ogawa S, Yamoto K, Okamoto S, Hama A, Hayashi I, Takamatsu H, Magata Y.

Neuropharmacology. 2019 May 1;149:204-211. doi: 10.1016/j.neuropharm.2019.02.031. Epub 2019 Feb 25.

PMID:
30817933
12.

Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents.

Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A.

Bone Marrow Transplant. 2019 Feb 19. doi: 10.1038/s41409-019-0478-4. [Epub ahead of print]

PMID:
30783208
13.

Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):377-381. doi: 10.1007/s12185-019-02615-z. Epub 2019 Feb 18. Erratum in: Int J Hematol. 2019 Mar 21;:.

PMID:
30778767
14.

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society.

Abe Y, Sunami K, Yamashita T, Ueda M, Takamatsu H, Narita K, Kobayashi H, Kitadate A, Takeuchi M, Matsue K.

Oncotarget. 2019 Jan 15;10(5):595-605. doi: 10.18632/oncotarget.26562. eCollection 2019 Jan 15.

15.

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Apr;109(4):409-417. doi: 10.1007/s12185-019-02607-z. Epub 2019 Jan 31. Erratum in: Int J Hematol. 2019 Jul;110(1):125-126.

PMID:
30701467
16.

Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men.

Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Andersson KE, Takeda M.

World J Urol. 2019 Jan 23. doi: 10.1007/s00345-019-02647-4. [Epub ahead of print]

PMID:
30673830
17.

Pain-related behavior and brain activation in cynomolgus macaques with naturally occurring endometriosis.

Yano M, Matsuda A, Natsume T, Ogawa S, Awaga Y, Hayashi I, Hama A, Takamatsu H.

Hum Reprod. 2019 Mar 1;34(3):469-478. doi: 10.1093/humrep/dey383.

PMID:
30597044
18.

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.

Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, Nakanishi Y, Suga Y, Nishijima-Futami Y, Osa A, Nakatani T, Kato Y, Nishide M, Hayama Y, Higashiguchi M, Morimura O, Miyake K, Kang S, Minami T, Hirata H, Iwahori K, Takimoto T, Takamatsu H, Takeda Y, Hosen N, Hoshino S, Shintani Y, Okumura M, Kumagai T, Nishino K, Imamura F, Nakatsuka SI, Kijima T, Kida H, Kumanogoh A.

JCI Insight. 2018 Dec 20;3(24). pii: 123093. doi: 10.1172/jci.insight.123093.

19.

Response to: 'Some concerns from Turkey' by Bilgin et al.

Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, Tanaka Y, Abe T, Takeuchi T.

Ann Rheum Dis. 2018 Dec 8. pii: annrheumdis-2018-214776. doi: 10.1136/annrheumdis-2018-214776. [Epub ahead of print] No abstract available.

PMID:
30530826
20.

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, Atsuta Y, Sunami K.

Biol Blood Marrow Transplant. 2019 Mar;25(3):474-479. doi: 10.1016/j.bbmt.2018.11.003. Epub 2018 Nov 10.

PMID:
30423479
21.

Response to e-letter: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.

Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, Tanaka Y, Abe T, Takeuchi T.

Ann Rheum Dis. 2018 Nov 10. pii: annrheumdis-2018-214653. doi: 10.1136/annrheumdis-2018-214653. [Epub ahead of print] No abstract available.

PMID:
30415202
22.

SEMA4A promotes eosinophil survival and contributes to eosinophil-mediated allergic diseases.

Maeda Y, Tsuda T, Takeda Y, Koyama S, Hayama Y, Nojima S, Kimura T, Ito D, Takamatsu H, Kang S, Nishide M, Morimoto K, Hosokawa T, Kinehara Y, Kato Y, Nakatani T, Takeda K, Hayama M, Obata S, Akazawa H, Shikina T, Inohara H, Kumanogoh A.

Allergol Int. 2019 Apr;68(2):274-276. doi: 10.1016/j.alit.2018.10.001. Epub 2018 Oct 19. No abstract available.

23.

[Methods and clinical values for minimal residual disease detection in patients with multiple myeloma].

Takamatsu H.

Rinsho Ketsueki. 2018;59(10):2153-2161. doi: 10.11406/rinketsu.59.2153. Review. Japanese.

PMID:
30305521
24.

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.

Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A.

JCI Insight. 2018 Oct 4;3(19). pii: 59125. doi: 10.1172/jci.insight.59125.

25.

Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.

Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, Tanaka Y, Abe T, Takeuchi T.

Ann Rheum Dis. 2018 Dec;77(12):1720-1729. doi: 10.1136/annrheumdis-2018-213920. Epub 2018 Oct 2.

PMID:
30279267
26.

Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity.

Tsuda T, Maeda Y, Nishide M, Koyama S, Hayama Y, Nojima S, Takamatsu H, Okuzaki D, Kinehara Y, Kato Y, Nakatani T, Obata S, Akazawa H, Shikina T, Takeda K, Hayama M, Inohara H, Kumanogoh A.

Int Immunol. 2019 Feb 6;31(1):33-40. doi: 10.1093/intimm/dxy061.

27.

[Pharmacological profile of a novel nonhuman primate model of knee osteoarthritis].

Ogawa S, Natsume T, Takamatsu H.

Nihon Yakurigaku Zasshi. 2018;152(3):132-138. doi: 10.1254/fpj.152.132. Japanese.

PMID:
30185731
28.

Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.

Hosokawa K, Sugimori C, Ishiyama K, Takamatsu H, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura JI, Kanakura Y, Nakao S.

Ann Hematol. 2018 Dec;97(12):2289-2297. doi: 10.1007/s00277-018-3443-1. Epub 2018 Jul 24.

PMID:
30039297
29.

Clinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney disease.

Ono Y, Takamatsu H, Inoue M, Mabuchi Y, Ueda T, Suzuki T, Kurabayashi M.

Drug Discov Ther. 2018;12(3):154-160. doi: 10.5582/ddt.2018.01007.

30.

Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.

Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S, Ueda M, Nishide M, Koyama S, Hayama Y, Kinehara Y, Hirano T, Shima Y, Narazaki M, Kumanogoh A.

Ann Rheum Dis. 2018 Oct;77(10):1507-1515. doi: 10.1136/annrheumdis-2018-212988. Epub 2018 Jun 26.

31.

Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.

Hama A, Natsume T, Ogawa S, Higo N, Hayashi I, Takamatsu H.

Pain Res Manag. 2018 May 2;2018:1630709. doi: 10.1155/2018/1630709. eCollection 2018. Review.

32.

Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization.

Kang S, Nakanishi Y, Kioi Y, Okuzaki D, Kimura T, Takamatsu H, Koyama S, Nojima S, Nishide M, Hayama Y, Kinehara Y, Kato Y, Nakatani T, Shimogori T, Takagi J, Toyofuku T, Kumanogoh A.

Nat Immunol. 2018 Jun;19(6):561-570. doi: 10.1038/s41590-018-0108-0. Epub 2018 May 18.

PMID:
29777213
33.

Pain-Related Behavior and Brain Activation in a Cynomolgus Macaque Model of Postoperative Pain.

Hama A, Natsume T, Ogawa SY, Awaga Y, Hayashi I, Matsuda A, Takamatsu H.

CNS Neurol Disord Drug Targets. 2018;17(5):348-360. doi: 10.2174/1871527317666180515121350.

PMID:
29766827
34.

Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB.

Hayama Y, Kimura T, Takeda Y, Nada S, Koyama S, Takamatsu H, Kang S, Ito D, Maeda Y, Nishide M, Nojima S, Sarashina-Kida H, Hosokawa T, Kinehara Y, Kato Y, Nakatani T, Nakanishi Y, Tsuda T, Koba T, Okada M, Kumanogoh A.

J Immunol. 2018 Jun 1;200(11):3790-3800. doi: 10.4049/jimmunol.1701283. Epub 2018 Apr 23.

35.

Long-term outcomes of surgery for choledochal cysts: a single-institution study focusing on follow-up and late complications.

Mukai M, Kaji T, Masuya R, Yamada K, Sugita K, Moriguchi T, Onishi S, Yamada W, Kawano T, Machigashira S, Nakame K, Takamatsu H, Ieiri S.

Surg Today. 2018 Sep;48(9):835-840. doi: 10.1007/s00595-018-1660-9. Epub 2018 Apr 20.

PMID:
29679145
36.

Increased systemic levels of inflammatory mediators following one-stage full-mouth scaling and root planing.

Morozumi T, Yashima A, Gomi K, Ujiie Y, Izumi Y, Akizuki T, Mizutani K, Takamatsu H, Minabe M, Miyauchi S, Yoshino T, Tanaka M, Tanaka Y, Hokari T, Yoshie H.

J Periodontal Res. 2018 Aug;53(4):536-544. doi: 10.1111/jre.12543. Epub 2018 Mar 30.

PMID:
29603738
37.

Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.

Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Takamatsu H, Ozawa T, Maruyama H, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S.

Blood Adv. 2018 Feb 27;2(4):390-400. doi: 10.1182/bloodadvances.2017013342. Erratum in: Blood Adv. 2018 Sep 11;2(17):2253.

38.

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation.

Takamatsu H, Wee RK, Zaimoku Y, Murata R, Zheng J, Moorhead M, Carlton VEH, Kong KA, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M, Nakao S.

Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22. No abstract available.

PMID:
29270982
40.

Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.

Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kikuchi K, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S.

PLoS One. 2017 Oct 10;12(10):e0185476. doi: 10.1371/journal.pone.0185476. eCollection 2017.

41.

Development of a Novel Scanning Thermal Microscopy (SThM) Method to Measure the Thermal Conductivity of Biological Cells.

Nakanishi K, Kogure A, Kuwana R, Takamatsu H, Ito K.

Biocontrol Sci. 2017;22(3):175-180. doi: 10.4265/bio.22.175.

43.

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.

Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton VEH, Kong KA, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M, Nakao S.

Ann Oncol. 2017 Oct 1;28(10):2503-2510. doi: 10.1093/annonc/mdx340.

44.

The novel preventive effect of Daikenchuto (TJ-100), a Japanese herbal drug, against neonatal necrotizing enterocolitis in rats.

Shinyama S, Kaji T, Mukai M, Nakame K, Matsufuji H, Takamatsu H, Ieiri S.

Pediatr Surg Int. 2017 Oct;33(10):1109-1114. doi: 10.1007/s00383-017-4145-9. Epub 2017 Aug 16.

PMID:
28815293
45.

Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function.

Hosokawa T, Kimura T, Nada S, Okuno T, Ito D, Kang S, Nojima S, Yamashita K, Nakatani T, Hayama Y, Kato Y, Kinehara Y, Nishide M, Mikami N, Koyama S, Takamatsu H, Okuzaki D, Ohkura N, Sakaguchi S, Okada M, Kumanogoh A.

J Immunol. 2017 Sep 15;199(6):2008-2019. doi: 10.4049/jimmunol.1700157. Epub 2017 Aug 2.

46.

Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity.

Nagasaka K, Yamanaka K, Ogawa S, Takamatsu H, Higo N.

Sci Rep. 2017 Jun 27;7(1):4305. doi: 10.1038/s41598-017-04677-7.

47.

Experimental study of thermal rectification in suspended monolayer graphene.

Wang H, Hu S, Takahashi K, Zhang X, Takamatsu H, Chen J.

Nat Commun. 2017 Jun 13;8:15843. doi: 10.1038/ncomms15843.

48.

Assessment of thermal damage in total knee arthroplasty using an osteocyte injury model.

Kurata K, Matsushita J, Furuno A, Fujino J, Takamatsu H.

J Orthop Res. 2017 Dec;35(12):2799-2807. doi: 10.1002/jor.23600. Epub 2017 May 23.

49.

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis.

Nishide M, Nojima S, Ito D, Takamatsu H, Koyama S, Kang S, Kimura T, Morimoto K, Hosokawa T, Hayama Y, Kinehara Y, Kato Y, Nakatani T, Nakanishi Y, Tsuda T, Park JH, Hirano T, Shima Y, Narazaki M, Morii E, Kumanogoh A.

Ann Rheum Dis. 2017 Aug;76(8):1440-1448. doi: 10.1136/annrheumdis-2016-210706. Epub 2017 Apr 17.

50.

Erratum: Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals.

Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, Ito D, Morimoto K, Hosokawa T, Hayama Y, Mitsui Y, Sakurai N, Sarashina-Kida H, Nishide M, Maeda Y, Takamatsu H, Okuzaki D, Yamada M, Okada M, Kumanogoh A.

Nat Commun. 2017 Feb 27;8:14711. doi: 10.1038/ncomms14711. No abstract available.

Supplemental Content

Loading ...
Support Center